Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery
Zhao, Y
Current therapeutic uses for CJC-1295 and ipamorelin Like sermorelin, another growth hormone secretagogue, CJC-1295 and ipamorelin are non-FDA-approved medications whose therapeutic uses are entirely off-label
69:E381
Key characteristics: Structure: Five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH2) Classification: Third-generation GHRP Mechanism: Growth hormone secretagogue receptor (GHS-R) agonist Half-life: Approximately 2 hours Administration: Subcutaneous injection Ipamorelin was initially developed to accelerate gastrointestinal recovery after bowel surgery
US$ 24.88
US$ 23.55
US$ 29.77
